Infectologia

Estudo falho sobre ivermectina destaca os desafios dos estudos sobre medicamentos para COVID.

6 Ago, 2021 | 11:49h

Flawed ivermectin preprint highlights challenges of COVID drug studies – Nature

Conteúdos relacionados:

Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

Why was a major study on ivermectin for covid-19 just retracted?

---

Revisão sobre COVID-19: manifestações abdominais em adultos e síndrome inflamatória multissistêmica em crianças.

6 Ago, 2021 | 11:47h

Review of COVID-19, part 1: Abdominal manifestations in adults and multisystem inflammatory syndrome in children – Clinical Imaging

---

M-A | Achados de radiografia torácica na COVID-19.

6 Ago, 2021 | 11:45h

Systematic review and meta-analysis of chest radiograph (CXR) findings in COVID-19 – Clinical Imaging

---

Anormalidades pulmonares intersticiais fibróticas no seguimento de 1 ano com tomografia computadorizada (TC) após COVID-19 grave.

6 Ago, 2021 | 11:43h

Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19 – Radiology

Conteúdo relacionado: Postacute Sequelae of COVID-19 Pneumonia: 6-month Chest CT Follow-up.

 

Comentário no Twitter

Data on 1 year outcomes for patients with post-COVID lung fibrosis. Small study, very little clinical information, including on treatment, and I object to the use of the term ILA, but overall not suggestive of progressive fibrotic lung disease. Thoughts?https://t.co/Kdt1pmTREl pic.twitter.com/mu1Jd2G6sd

— Anna Podolanczuk (@AnnaPodolanczuk) August 4, 2021

 

---

Diretriz PIDS-IDSA sobre diagnóstico e tratamento da osteomielite hematogênica aguda em pediatria.

6 Ago, 2021 | 11:40h

Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics – Journal of the Pediatric Infectious Diseases Society

Comunicado de imprensa: New PIDS-IDSA guideline on bone infections in children addresses key diagnostic and treatment questions – Pediatric Infectious Diseases Society

---

Revisão | Reanimação com fluidos na sepse para o hospitalista.

6 Ago, 2021 | 11:35h

A Narrative Review Rational Fluid Resuscitation in Sepsis for the Hospitalist: A Narrative Review – Mayo Clinic Proceedings

---

Pesquisadores afirmam que médicos devem abandonar os exames de urina de rotina em pacientes idosos com delirium.

6 Ago, 2021 | 11:27h

Researchers tell doctors to avoid routine urinary tests for older patients with delirium – Johns Hopkins University School of Medicine

Artigo original: Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection – Journal of Hospital Medicine ($)

 

Comentário no Twitter (fio – clique para saber mais)

1/14
Hey #MedTwitter!

Ever question the utility of asymptomatic urine testing in delirious, older patients?

Passionate about avoiding low-value tests that may harm vulnerable patients?

If so, please join us on this Tweetorial journey based on our @JHospMedicine @TWDFNR piece! pic.twitter.com/vNsTL5UpUK

— Milad Memari, MD (@MemariMD) July 28, 2021

 

---

Estudo randomizado | Em pacientes não críticos hospitalizados com Covid-19, anticoagulação com heparina em dose terapêutica aumentou a probabilidade de sobrevivência à alta em comparação com a tromboprofilaxia usual.

5 Ago, 2021 | 12:02h

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 – New England Journal of Medicine

Editorial: Surviving Covid-19 with Heparin?

Comentários:

Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients – National Institutes of Health

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t – TCTMD

Canadian-Led International Study: Full-Dose Blood Thinners Benefit Moderately Ill COVID-19 Patients – University of Manitoba

 

Comentário no Twitter

In noncritically ill patients with #COVID19, anticoagulation increased the probability of survival to hospital discharge without organ support. https://t.co/3JzKdmL3SB #IDTwitter pic.twitter.com/iDjSelp2HL

— NEJM (@NEJM) August 4, 2021

 

---

Estudo randomizado | Em pacientes críticos hospitalizados com Covid-19, anticoagulação em dose terapêutica com heparina não resultou em melhores desfechos em comparação com a tromboprofilaxia farmacológica usual.

5 Ago, 2021 | 12:00h

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 – New England Journal of Medicine

Editorial: Surviving Covid-19 with Heparin?

Comentários:

Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients – National Institutes of Health

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t – TCTMD

 

Comentário no Twitter

Anticoagulation did not improve hospital survival in critically Ill patients with #COVID19. https://t.co/E8RXE01jbF pic.twitter.com/9idGxgbUas

— NEJM (@NEJM) August 4, 2021

 

---

Variantes do SARS-CoV-2 em pacientes imunossuprimidos.

5 Ago, 2021 | 11:58h

SARS-CoV-2 Variants in Patients with Immunosuppression – New England Journal of Medicine

 

Comentário no Twitter

In the pandemic, immunocompromised people (~3% of Americans) are not getting adequate recognition for the potential of in-host evolution of the virus (highlighted studies) and the need for far better approaches to protect them https://t.co/XDT1VxC9ZK @NEJM pic.twitter.com/ciw1WD9EzC

— Eric Topol (@EricTopol) August 4, 2021

 

---